201 related articles for article (PubMed ID: 37257708)
1. Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.
Xu J; Tian Z; Li Z; Du X; Cui Y; Wang J; Gao M; Hou Y
J Ethnopharmacol; 2023 Dec; 317():116675. PubMed ID: 37257708
[TBL] [Abstract][Full Text] [Related]
2. Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2.
Ma X; Zhang L; Gao F; Jia W; Li C
Biomed Pharmacother; 2023 Nov; 167():115501. PubMed ID: 37713995
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages.
Liu QY; Zhuang Y; Song XR; Niu Q; Sun QS; Li XN; Li N; Liu BL; Huang F; Qiu ZX
Acta Pharmacol Sin; 2021 Jun; 42(6):987-997. PubMed ID: 33028985
[TBL] [Abstract][Full Text] [Related]
4. Succinate/IL-1β Signaling Axis Promotes the Inflammatory Progression of Endothelial and Exacerbates Atherosclerosis.
Xu J; Zheng Y; Zhao Y; Zhang Y; Li H; Zhang A; Wang X; Wang W; Hou Y; Wang J
Front Immunol; 2022; 13():817572. PubMed ID: 35273600
[TBL] [Abstract][Full Text] [Related]
5. Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway.
Huang H; Sun Z; Xu J; Wang L; Zhao J; Li J; Zhang S; Yuan F; Liu M; Fang Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116868. PubMed ID: 37454749
[TBL] [Abstract][Full Text] [Related]
6. Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats
Miao Q; Wang R; Sun X; Du S; Liu L
Pharm Biol; 2022 Dec; 60(1):1022-1031. PubMed ID: 35635784
[TBL] [Abstract][Full Text] [Related]
7. Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice.
Yao J; Liu J; He Y; Liu L; Xu Z; Lin X; Liu N; Kai G
J Ethnopharmacol; 2023 Sep; 313():116533. PubMed ID: 37100262
[TBL] [Abstract][Full Text] [Related]
8. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
9. Cinnamaldehyde suppresses NLRP3 derived IL-1β via activating succinate/HIF-1 in rheumatoid arthritis rats.
Liu P; Wang J; Wen W; Pan T; Chen H; Fu Y; Wang F; Huang JH; Xu S
Int Immunopharmacol; 2020 Jul; 84():106570. PubMed ID: 32413739
[TBL] [Abstract][Full Text] [Related]
10. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis.
Yang C; Mu Y; Li S; Zhang Y; Liu X; Li J
Front Pharmacol; 2023; 14():1321880. PubMed ID: 38108067
[TBL] [Abstract][Full Text] [Related]
13. Study of Therapeutic Mechanisms of Puerarin against Sepsis-Induced Myocardial Injury by Integrating Network Pharmacology, Bioinformatics Analysis, and Experimental Validation.
Li Y; Feng L; Bai L; Jiang H
Crit Rev Immunol; 2023; 43(3):25-42. PubMed ID: 37824375
[TBL] [Abstract][Full Text] [Related]
14. Dan-Lou tablets reduces inflammatory response via suppression of the MyD88/p38 MAPK/NF-κB signaling pathway in RAW 264.7 macrophages induced by ox-LDL.
Li Z; Cheng Q; Yu L; He YY; Gao LN; Wang Y; Li L; Cui YL; Gao S; Yu CQ
J Ethnopharmacol; 2022 Nov; 298():115600. PubMed ID: 35970313
[TBL] [Abstract][Full Text] [Related]
15. Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway.
Guan R; Wang J; Li Z; Ding M; Li D; Xu G; Wang T; Chen Y; Yang Q; Long Z; Cai Z; Zhang C; Liang X; Dong L; Zhao L; Zhang H; Sun D; Lu W
Front Pharmacol; 2018; 9():263. PubMed ID: 29765317
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
[TBL] [Abstract][Full Text] [Related]
17. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J
Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis.
Aarup A; Pedersen TX; Junker N; Christoffersen C; Bartels ED; Madsen M; Nielsen CH; Nielsen LB
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1782-90. PubMed ID: 27444197
[TBL] [Abstract][Full Text] [Related]
19. Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism.
Wang X; Du H; Li X
Int Immunopharmacol; 2022 Jan; 102():108413. PubMed ID: 34891003
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the underlying mechanism of Astragaloside III in attenuating immunosuppression via network pharmacology and vitro/vivo pharmacological validation.
He Y; Amer HM; Xu Z; Liu L; Wu S; He B; Liu J; Kai G
J Ethnopharmacol; 2024 Aug; 330():118235. PubMed ID: 38648891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
